Platinum Investment Management’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-346,352
Closed -$423K 137
2024
Q3
$423K Hold
346,352
0.02% 92
2024
Q2
$717K Sell
346,352
-540,430
-61% -$1.27M 0.03% 87
2024
Q1
$3.24M Hold
886,782
0.13% 56
2023
Q4
$2.67M Sell
886,782
-235
-0% -$476 0.11% 74
2023
Q3
$1.91M Sell
887,017
-1,318
-0.1% -$5.27K 0.07% 82
2023
Q2
$4.97M Sell
888,335
-34,956
-4% -$273K 0.17% 55
2023
Q1
$5.57M Buy
923,291
+339,553
+58% +$2.36M 0.19% 53
2022
Q4
$3.33M Sell
583,738
-47,341
-8% -$266K 0.13% 64
2022
Q3
$3.42M Sell
631,079
-63,352
-9% -$321K 0.14% 57
2022
Q2
$2.64M Buy
694,431
+279,918
+68% +$1.04M 0.1% 72
2022
Q1
$2.59M Hold
414,513
0.08% 76
2021
Q4
$4.7M Sell
414,513
-85,487
-17% -$1.63M 0.13% 64
2021
Q3
$9.43M Buy
+500,000
New +$9.59M 0.27% 46

Other funds holding OMGA

Platinum Investment Management's OMGA Position: Q4 2024 in Review

Platinum Investment Management sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q4 2024, closing a stake of 346,352 shares — an estimated $423K sold.

Platinum Investment Management first reported a position in OMGA in Q3 2021 and held it in 13 quarters. The position peaked at $9.43M in Q3 2021. 53 funds tracked by Wall St. Rank hold OMGA as of Q4 2024.

  • Platinum Investment Management reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Platinum Investment Management sold 346,352 Omega Therapeutics, Inc. Common Stock shares in Q4 2024, an estimated $423K.
  • Platinum Investment Management first reported a position in Omega Therapeutics, Inc. Common Stock in Q3 2021 and held it in 13 quarters.
  • Platinum Investment Management's Omega Therapeutics, Inc. Common Stock position peaked at $9.43M in Q3 2021.
  • 53 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q4 2024.

Based on Platinum Investment Management's 13F filing for Q4 2024, filed 11 Feb 2025.